Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

por Hegele, Axel, Knippschild, Sonja, Frohme, Carsten, Hänze, Jörg, Olbert, Peter, Hofmann, Rainer
Publicado 2014